✦ LIBER ✦

Autologous stem cell transplantation for relapsed and primary refractory myeloma

✍ Scribed by Rajkumar, S V; Fonseca, R; Lacy, M Q; Witzig, T E; Lust, J A; Greipp, P R; Therneau, T M; Kyle, R A; Litzow, M R; Gertz, M A

Book ID: 110012047
Publisher: Nature Publishing Group
Year: 1999
Tongue: English
Weight: 59 KB
Volume: 23
Category: Article
ISSN: 0007-1188
DOI: 10.1038/sj.bmt.1701805

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Autologous transplantation for relapsed

Autologous transplantation for relapsed or primary refractory peripheral T-cell lymphoma

✍ Tarun Kewalramani; Andrew D. Zelenetz; Julie Teruya-Feldstein; Paul Hamlin; Joac 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB

Autologous stem cell transplantation for

Autologous stem cell transplantation for refractory Langerhans' cell histiocytosis

✍ Ichikawa, K; Nomura, S; Ishii, K; Okuno, M; Kasai, C; Maekawa, T; Kadota, E 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 137 KB

Autologous stem cell transplantation fol

Autologous stem cell transplantation followed by consolidation chemotherapy for relapsed or refractory Hodgkin's lymphoma

✍ Rapoport, A P; Guo, C; Badros, A; Hakimian, R; Akpek, G; Kiggundu, E; Meisenberg 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 261 KB

Autologous stem cell transplant for earl

Autologous stem cell transplant for early relapsed/refractory Hodgkin lymphoma: results from two transplant centres

✍ Stephen D. Smith; Craig H. Moskowitz; Robert Dean; Brad Pohlman; Ronald Sobecks; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB

Autologous and allogeneic stem cell tran

Autologous and allogeneic stem cell transplantation in multiple myeloma

✍ Goldschmidt, H; Egerer, G; Ho, A D 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 43 KB

Symptom burden after autologous stem cel

Symptom burden after autologous stem cell transplantation for multiple myeloma

✍ Erica Campagnaro; Rima Saliba; Sergio Giralt; Linda Roden; Floralyn Mendoza; Ana 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB

## Abstract ## BACKGROUND Multiple myeloma (MM) is the most common indication for high‐dose chemotherapy with autologous stem cell transplantation (ASCT) in the U.S. and can be associated with substantial morbidity. Thorough assessment and understanding of symptoms and risk factors for symptom dev